Drugs / Autologous Plasma Rich Platelets (PRP)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06600529 | Aug 2024 → Jun 2025 overdue | autism spectrum disorder | Iffat Anwar Medical Complex | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Plasma Rich Platelets (PRP) | “IV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.” NCT06600529 ↗ |
| Route | Intravenous | “IV injection of Autologous Plasma Rich Platelets (PRP) on Days 0, 15, 30, and 45.” NCT06600529 ↗ |